follow us:
Swiss pharmaceutical giant Novartis AG is exiting India by selling its 70.68% stake in Novartis India to ChrysCapital for ₹1,446 crore. Additionally, an open offer has been announced for an extra 26% stake, valued at ₹552 crore, at a price of ₹860.64 per share. The deal is expected to conclude by year-end, marking its complete exit.